Search for: "The Medicines Company" Results 81 - 100 of 9,185
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Oct 2008, 7:27 am
Another part of the agency's work includes outreach to other public health agencies, consumer and patient groups companies that manufacture these products, and CHPA. [read post]
19 Nov 2010, 10:40 am by Greenberg & Bederman
The “crisis” of “preventive medicine” putting an undue burden on insurance companies does not exist. [read post]
29 Apr 2024, 10:00 pm
The European Commission on April 19 opened a public consultation on commitments proposed by Vifor Pharma in response to a formal investigation into allegations of anticompetitive practices related to disparaging claims about an intravenous iron medicine supplied by a competitor. [read post]
29 Apr 2024, 10:00 pm
The European Commission on April 19 opened a public consultation on commitments proposed by Vifor Pharma in response to a formal investigation into allegations of anticompetitive practices related to disparaging claims about an intravenous iron medicine supplied by a competitor. [read post]
29 Apr 2024, 10:00 pm
The European Commission on April 19 opened a public consultation on commitments proposed by Vifor Pharma in response to a formal investigation into allegations of anticompetitive practices related to disparaging claims about an intravenous iron medicine supplied by a competitor. [read post]
29 Apr 2024, 10:00 pm
The European Commission on April 19 opened a public consultation on commitments proposed by Vifor Pharma in response to a formal investigation into allegations of anticompetitive practices related to disparaging claims about an intravenous iron medicine supplied by a competitor. [read post]
29 Apr 2024, 10:00 pm
The European Commission on April 19 opened a public consultation on commitments proposed by Vifor Pharma in response to a formal investigation into allegations of anticompetitive practices related to disparaging claims about an intravenous iron medicine supplied by a competitor. [read post]
29 Apr 2024, 10:00 pm
The European Commission on April 19 opened a public consultation on commitments proposed by Vifor Pharma in response to a formal investigation into allegations of anticompetitive practices related to disparaging claims about an intravenous iron medicine supplied by a competitor. [read post]
30 Apr 2010, 4:04 pm by jly
This comes on the heels of a revealing study which indicates that doctors are not pleased with the way their ability to practice medicine is affected by third parties. [read post]
14 Jan 2015, 4:34 pm by Sabrina I. Pacifici
“Our agreement with YODA exemplifies the Johnson & Johnson family of companies’ commitment to science, medicine and public health by creating a standardized independent, transparent and reproducible process for sharing our clinical trial data. [read post]
10 Feb 2012, 1:36 pm by Hopkins
Not in the best interest of insurance companies or physicians, but in the best interest of the patient. [read post]
10 Feb 2012, 1:36 pm by Hopkins
Not in the best interest of insurance companies or physicians, but in the best interest of the patient. [read post]
10 Nov 2015, 9:40 am by Lisa Baird
As reported in Mergermarket’s Deal Dimensions series titled Life lines: Life sciences M&A and the rise of personalised medicine, 94 per cent of life sciences companies are planning an acquisition in the next year, with more than two-thirds (70 per cent) of respondents targeting personalised medicine. [read post]
13 Feb 2007, 11:12 am
The New York Times reports that in February there will be a new push announced by Community Catalyst, a health care consumer advocacy group based in Boston, and the Institute on Medicine as a Profession, a research group at Columbia... [read post]
13 Jun 2019, 12:26 pm by Kluwer Patent blogger
Kluwer Patent bloggerThe focus in The Netherlands on the option of compounding medicines as a means to circumvent the use of (expensive) authorised medicinal products of pharmaceutical companies and to pressurize them into lowering their prices, is confusing and possibly misleading and not necessarily good for patients. [read post]
2 Mar 2022, 2:44 am by Frantzeska Papadopoulou
She has gained extensive experience advising a wide range of companies within the life sciences industry, including pharma, MedTech, healthcare and food companies. [read post]
The event brings together stakeholders from financial entities, life sciences companies, care providers, and research and policy organizations to discuss critical insights and solutions for product development, commercialization, and mainstream implementation at the point of care. [read post]